Company profile for ReNeuron

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. We have used our unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional drug tr...
We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. We have used our unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered “off-the-shelf” to any eligible patient without the need for additional drug treatments.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Pencoed Business Park, Pencoed, Bridgend CF35 5HY
Telephone
Telephone
+44 (0) 203 819 8400
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-03-19/reneuron-establishes-new-base-at-swansea-university-s-institute-of-life-science-in-major-research-partnership

PHARMIWEB
19 Mar 2026

https://www.fiercebiotech.com/biotech/reneuron-joins-exodus-aim-exchange-after-missing-fundraising-goal

FIERCE BIOTECH
30 Aug 2024
ReNeuron lays off 40% of staff to buy time for exosome pivot
ReNeuron lays off 40% of staff to buy time for exosome pivot

19 Jan 2023

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/reneuron-lays-40-staff-after-funding-failure-buying-time-pull-exosome-pivot

Nick Paul Taylor FIERCE BIOTECH
19 Jan 2023

https://www.rttnews.com/3301124/reneuron-appoints-catherine-isted-as-ceo.aspx

RTTNEWS
01 Aug 2022
Director Change
Director Change

11 Feb 2022

// RENEURON

https://www.reneuron.com/wp-content/uploads/RENE-Director-Change-11.02.22.pdf

RENEURON
11 Feb 2022

https://www.reneuron.com/news-list/first-subject-treated-at-oxford-eye-hospital-in-phase-2a-rp-trial/

RENEURON
18 Oct 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty